***Background.*** At SIM Galmi Hospital in south-central Niger, we follow the national protocol for HIV testing, employing the Determine and ImmunoComb II kits in a serial approach. While this yields an expected sensitivity of 100%, specificity is only 91.5%, and conditions such as pregnancy increase the likelihood of a false positive result. Many Africans, especially pregnant women, are thus inaccurately labeled as HIV-positive, with diverse personal and societal costs.

***Methods.*** We assessed 3957 persons diagnosed as HIV positive at our institution 2005-2011, and in a previous publication developed a protocol to identify 127 who were especially likely to be falsely labeled as HIV positive, based on CD4 and clinical criteria. This cohort included 75 pregnant women, the very population that yields the highest costs, as they are socially vulnerable and routinely started on ARVs. Through analysis and interviews with our HIV-positive population, we then attempted to quantify and assess the costs of false diagnoses.

***Results.*** Considering 405 HIV positive diagnoses from 24,977 pregnant women screened at our institution in 2008-13, a 91.5% specificity suggests that 34 of these women were falsely labeled. Since pregnant women are routinely started on ARVs under the national PMTCT protocol, our center may annually draw \$4957 in inappropriate ARV pharmaceutical costs alone. Beyond the programmatic financial burden, other costs are significant although harder to quantify. Women receiving an HIV diagnosis face challenges that can be psychological (for example, depression), physical (ARV and other medication side effects), professional (reduced job opportunities), social (shunning by her neighbors), and sexual (even divorce by a seronegative husband). The child may be viewed and treated unfavorably, and may be weaned more rapidly than necessary. Finally, the community and even health care workers lose trust in the accuracy of the diagnosis with repeated lab tests giving variant results.

***Conclusion.*** Inaccurate HIV diagnoses, especially among pregnant women, result in extensive financial, physical, psychological, and societal costs, and represents a growing problem in the developing world. Our study highlights the importance of the employment of protocols and confirmatory laboratory testing to identify falsely labeled persons.
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